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1078–5Aim. To compare the results of endovascular repair (EVAR) in large and small (diameter < 5.5 cm) abdominal aortic
aneurysms (AAA).
Methods. A systematic review was performed to identify studies comparing the outcomes after EVAR of large and small
aneurysms. Outcomes considered were: risk of death (perioperative, all cause, aneurysm-related), ruptures, and complica-
tions (conversion, reintervention). Weighted pooled estimates of outcomes in patients with small versus large aneurysms
were calculated. The inverse variance method was used (random-effect model). Subgroup analyses by a follow-up longer or
shorter than 24 months were performed.
Results. Five studies, with published and unpublished data, totallying 7,735 patients, were included. Overall, the
weighted pooled estimates were: OR 0.68; 95% CI 0.51e0.90 for operative mortality, OR 0.77; 95% CI 0.69 to 0.86
for all cause mortality, OR 0.58; 95% CI 0.40 to 0.87 for aneurysm-related mortality and OR 0.61; 95% CI 0.47 to
0.79 for rupture in favour of small AAA group. Pooled estimates were not influenced by follow-up length. Conversion
and reintervention rates were not significantly lower for small AAA.
Conclusions. EVAR in small versus large AAA might be associated with lower operative mortality, aneurysm-related
mortality and aneurysm rupture. Better evidence is needed to support these suggestions.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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the ‘‘waiting and watching’’ policy is preferred to sur-
gical treatment for abdominal aortic aneurysms
(AAA) of 5.5 cm or less since early surgical risks
will not be overcome by late risks of rupture.1,2 How-
ever, the optimal strategy to treat patients with small
AAA has been challenged since the introduction of
endografting with the appealing prospective of offer-
ing fewer perioperative risks but undefined durability
in the long term.
RCTs comparing open vs. endovascular aneurysm
repair (EVAR) have failed to show evident mid-term
benefit for EVAR in terms of improving all cause mor-
tality with respect to open repair.3,4 Nevertheless, RCTssponding author: P. Cao, MD, FRCS, Professor of Vascular
y, University of Perugia, Chief of Vascular and Endovascular
y, Ospedale S. Maria della Misericordia, Loc. S. Andrea delle
06156 Perugia, Italy.
address: pcao@unipg.it
884/000162 + 11 $34.00/0  2007 European Society for Vasculaon EVAR analyzed populations exclusively with large
AAA, whereas RCTs on small AAA established their
results based on populations treated by open surgery
or medical treatment. Consequently, it has been ques-
tioned whether the findings from both types of RCTs
can be applied to small AAA treated by EVAR. The
majority of studies reporting on EVAR include patients
with both small and large aneurysms, whereas only
a few studies have specifically addressed the outcome
in subgroups of small vs. large AAA using a threshold
diameter.5e11 Some Authors reported better early and
mid-term results in patients with small AAA, but the
precise relationship between aneurysm size and out-
come is yet to be defined. Furthermore, since small
AAAs also represent an earlier stage of disease, the
consequent expected benefit may be low and more
extensive efforts are needed to clarify the issue.
A systematic review of recent studies comparing
the outcome of small vs large AAA treated by EVAR
was performed to investigate early and long-termr Surgery. Published by Elsevier Ltd. All rights reserved.
163Outcome after Endografting in Small and Large Abdominal Aortic Aneurysmsoutcomes using a threshold diameter of 5.5 cm (small
< 5.5 cm vs large: > 5.5 cm).Materials and Methods
An extensive search of the literature was performed us-
ing a strategy designed to identify all relevant studies
on EVAR with stratified results according to aneurysm
diameter (small vs. large AAA). To avoid the con-
founding effect of old generation devices no longer in
use today, case series before 1996 were excluded, and
the search was restricted to English-language articles
published between January 2000 and February 2007.
Studies were initially identified from the Cochrane
Library and Medline Database using the search terms
‘‘aneurysm endografting’’, ‘‘aneurysm diameter’’,
’’small aneurysm’’, ‘‘large aneurysm’’, ‘‘aortic endo-
vascular’’. Additional papers were identified from ref-
erence lists of retrieved articles or by hand search of the
2 most frequently identified journals by the electronic
search (Journal of Vascular Surgery and European Journal
of Vascular and Endovascular Surgery).
The search attempted to identify all comparative
studies, case series studies, and population-based reg-
istries assessing efficacy of EVAR in large or small
AAA using a threshold diameter of 5.5 cm.
Studies were included when compliant with the
following criteria:
1. The numbers of operative deaths and/or late
deaths after EVAR were indicated.
2. The risk of peroperative or late death, aneurysm-
related death, conversion, and reintervention after
EVAR was defined and calculable, per operation.
3. A 5.5 cm threshold diameter to separate large and
small AAA was used.
Studies were excluded when:
1. The risks of EVAR were considered but data on small
vs. large aneurysms were not reported separately.
2. The risks of EVAR were reported by aneurysm dia-
meter but without the threshold diameter of 5.5 cm.
3. Thoracic and thoracoabdominal aortic aneurysms
or patients with symptomatic or ruptured aneu-
rysms were included.
4. Case series comprised fewer than 50 patients or
case reports.
Two researchers (P.D.R. and D.B.) screened the list
of references individually to identify any report that
stratified EVAR outcome according to aneurysm di-
ameter. The methodological quality of all paperswas assessed by one reviewer and then checked inde-
pendently by another. A data extraction form was
developed specifically to record details of the design
of included studies, characteristics of participants,
and outcome measures of interest. Data on the out-
comes during the operative and postoperative period
were recorded. Where duplication was considered
likely, only one paper was included. Duplicated pub-
lications from the same Authors were included once,
based on the largest series and the most detailed
information presented. Attempts also were made to
detect any possible overlapping of cases in the multi-
center published series. After exclusion of duplicates,
a final database of articles was created for analysis.
Authors were contacted for additional unpublished
data where necessary. Unpublished data from the au-
thors own single centre experience also were included
in the analysis according to the above criteria.
Meta analysis was performed to calculate the over-
all risk of peri-operative (within 30 days of procedure)
and late death, aneurysm-related death, rupture, con-
version to open repair, and re-intervention after EVAR
in small and large AAA. We followed the QUORUM
guidelines in the preparation of our review (http://
www.consort-statement.org).Statistical analysis
Statistical analysis was carried out using the Revman
software Version 4.2 for Windows (The Cochrane Col-
laboration, Oxford, UK).
Results were reported as odds ratios (OR). The
odds of any outcome in patients with small aneu-
rysms treated by EVAR were compared to the corre-
sponding odds in patients with large AAA treated
by EVAR. Forest plots were used to illustrate the in-
formation from the individual studies in terms of
OR and 95% confidence interval (CI). The plots dem-
onstrated the variation between studies and a pooled
point estimate of the overall results, with 95% CI,
which represented the diameter-outcome relationship
in EVAR populations.
Pooled weighted estimates were calculated with
random-effect model of inverse variance method.
This method, widely applicable for meta-analyses, is
suggested particularly for analysis of non-randomized
studies.12Heterogeneity, sensitivity analysis and
subgroup analyses
Heterogeneity between estimates from individual
studies was tested for using a standardc2 test. A pvalueEur J Vasc Endovasc Surg Vol 35, February 2008
164 P. De Rango et al.of 0.10 was considered statistically significant. Sensitiv-
ity analyses were performed by comparing the results
obtained through both fixed and random effects analy-
ses. Subgroup analyses were applied according to dif-
ferent lengths of mean follow-up (longer and shorter
than 24 months) to determine whether studies with
shorter mean follow-up might have influenced the
results.
Results
Search Results
From a total of 60 papers identified in the literature
search, 17 were potentially relevant for EVAR in small
vs. large AAA.4e11,13e21 Full papers were obtained
and assessed in detail. One RCT using a threshold of
5 cm and one single centre study that had an undeter-
mined threshold for large AAA were excluded.13,14
Papers analyzing predictors of outcome in large ver-
sus small AAA without detailed information on major
outcome data15e17 and studies published exclusively
using life table methods without calculable crude
numbers and numbers at risk,18,19 also were excluded
when a complete data sheet was not available after di-
rect contact with the authors. Two other excluded
studies were duplicated publications from the same
authors.20,21 Finally, 4 papers were excluded because
they analyzed exclusively large or small AAA without
comparison between the two groups.4,6,10,11
Four full-text papers met the criteria for
inclusion.5,7,8,9
Two were observational studies comparing small
versus large AAA.
1. Brewster et al., reviewed a prospective series of
873 EVAR and compared early and late outcomes
in 424< 5.5 cm and 439> 5.5 cm AAA.5
2. Ouriel et al. reported 700 EVAR patients, 416 with
small AAA and 284 patients with large AAA, over
a 6-year period.7
Two studies were large multicentre EVAR regis-
tries: one European and one Australian.8,9
3. Eurostar analyzed three aneurysm sized groups:
group A, diameter< 5.5 cm, n¼ 1962 patients;
group B, 5.5 to 6.4 cm, n¼ 1528; group C, diameter
6.5 cm or more, n¼ 902. Groups B and C (com-
bined in the present meta-analysis) were com-
pared to group A.8
4. Golledge et al. reported a multicentre prospective
registry on small AAA (Australian Registry,
ASERNIP). Unpublished data from the largeEur J Vasc Endovasc Surg Vol 35, February 2008AAA control group were obtained by direct con-
tact with the author for some of the outcomes.9
Literature data were combined with the authors
own single centre experience on 835 EVAR (details
are reported in the Appendix) leaving a total of 5
studies available for meta-analysis.
All the included studies were non-randomized
with no level 1 evidence. The check list used to assess
the quality of these studies was adapted from Current
Methods of the U.S. Preventive Services Task Force: A
Review of the Process by Harris et al., and from
Downs and Blacks and included the quality in report-
ing, confounding bias and external validity.22,23 The
overall methodological quality of the included studies
was rated as ‘fair’ according to this formal assess-
ment. A summary of the main characteristics of the
included studies are shown in Table 1.
Depending on the reported outcome being available,
the total number of included patients ranged from 2398
to 7735. Mean follow-up for each study ranged from
12.1 to 39 months; in two studies it was < 24 months
and in the other three > 24 months. All studies had at
least 5 years of maximum follow-up to assess late out-
comes, ranging from 6 to 10 years in 4/5 studies.Meta Analysis results
Table 2 shows the main characteristics of the patient
population in each study.
Pooled estimates of outcomes using random-effect
model of inverse variance method are displayed in
Figs. 1 to 6.
Peri-operative mortality in a total of 6090 cases
ranged from 0% to 1.6% after EVAR in the small aneu-
rysm group and from 2% to 3.2% in the large group.
In the pooled estimate of the 3 studies reporting on
this outcome, lower peri-operative mortality was ob-
served in the small AAA group (OR 0.68; 95% CI
0.51 to 0.90; test for heterogeneity p¼ 0.30) (Fig. 1).
Data on all cause mortality were available from 3
studies (2398 cases), data on aneurysm-related death
rate from 3 studies (6090 cases) and data on AAA rup-
tures, after AAA repair, from 5 studies (7735 cases).
All cause mortality (OR 0.77; 95% CI 0.69 to 0.86;
test for heterogeneity p¼ 0.21), aneurysm-related
mortality (OR 0.58; 95% CI 0.40 to 0.87; test for hetero-
geneity p¼ 0.07) and aneurysm rupture rates, (OR
0.61; 95% CI 0.47 to 0.79; test for heterogeneity
p¼ 0.70) were all in favour of the small AAA group
(Figs. 2e4). Statistical heterogeneity was found for
AAA-related mortality.
Table 1. Characteristics of included studies
Study ID Studyperiod
Years
Methods Participants Interventions Outcomes Mean
Follow-up*
Notes
Brewster,
2006
1994e2005 Monocentric
observational
study
Small AAA
vs large
AAA
EVAR Perioperative
mortality, overall
mortality, AAA
related mortality
rupture,
conversion,
reinterventions
27 months
(maximum:
10 years)
EUROSTAR,
2004
1996e2002 Multicentric
registry
Small AAA
vs large
AAA
EVAR Perioperative
mortality, overall
mortality, AAA
related
mortality, rupture
20.4months
(maximum:
6 years)
European registry;
3 groups of AAA
by size: Group A
(4 to 5.4 cm),
Group B
(5.5 to 6.4 cm)
and Group C
(6.5 cm or larger)
Golledge,x
2007
1999e2001 Multicentric
registry
Small AAA
vs large
AAA
EVAR Perioperative
mortality, overall
mortality, AAA
related mortality
rupture,
conversion,
reinterventions
38months**
(maximum:
6 years)
ASERNIP-S
Australian registry
(Safety and
Efficacy Register of
New Interventional
Procedures-
Surgical).
Unpublished data
from large
aneurysm
group (contact with
Authors)
Ouriel,
2003
1996e2002 Monocentric
observational
study
Small AAA
vs large
AAA
EVAR Overall mortality,
rupture
12.1 months
(maximum:
5 years)
Perugia,
2007
1997e2007 Monocentric
observational
study
Small AAA
vs large
AAA
EVAR Perioperative
mortality, overall
mortality, AAA
related mortality
rupture,
conversion,
reinterventions
39 months
(maximum:
10 years)
AAA: Abdominal aortic aneurysm; EVAR: endovascular repair of abdominal aortic aneurysm.
* reliable data.

unpublished data.
x published and unpublished data.
** median.
165Outcome after Endografting in Small and Large Abdominal Aortic AneurysmsConversion and re-intervention rates after EVAR
were reported in three studies including 2643 pa-
tients; all were studies with follow-up of longer than
24 months. Although the conversion rate appeared
lower in the small AAA group, this was not signifi-
cant (OR 0.93; 95% CI 0.73 to 1.18; test for heterogene-
ity p¼ 0.23; Fig. 5). The secondary intervention rates
were similar in the small AAA (range 10e12%) and
large AAA groups (range 10.5e14.5%), OR 0.96; 95%
CI 0.86 to 1.06; test for heterogeneity p¼ 0.71; Fig. 6.Subgroup analysis results
Subgroup analyses according to follow-up length
were performed for all-cause mortality, AAA-relatedmortality, and rupture (Figs. 2e4). All results are re-
ported with random effect model, although fixed ef-
fect models also were used and generated similar
results.
In the 3 studies reporting on all cause mortality
there was a significant association with lower all
cause mortality in the small AAA group that persisted
after excluding the study with shortest follow-up (OR
0.80; 95% CI 0.71 to 0.90; test for heterogeneity
p¼ 0.22; Fig. 2), although these results were not ad-
justed for age (higher in the large AAA group).
Similarly, aneurysm-related death rate reported
from 3 studies showed a lower risk in small versus
large group of AAA, a finding that remained when
the study with shortest follow-up was excluded.
However, the heterogeneity in this outcome wasEur J Vasc Endovasc Surg Vol 35, February 2008
Table 2. Main characteristics of included patients
N Age Male % Smoke % CHD % CRF % COPD % Unfit/ASA >3% HTN % Diabetes %
Brewster 2006 TOT 873 75.7 81.4 65 57.2 9 (2% dialysis) 24 19.5 73.4 12.4
Small 424 74.9 e e e e e e e e
Large 439 76.4 e e e e e e e e
EUROSTAR 2004 TOT 4392
Small 1962 69.7 93 56 17 37 48 e e
Large 2430 73 93 61 18 41 57 e e
Golledgex 2006 Small 478 75 84 81 54 0.2 (dialysis) 23 58 67 11
Large 525
Ouriel 2003 TOT 700 758 86 e e e e e e e
Small 416 74.2 e e e e e e e e
Large 284 75.5 e e e e e e e e
Perugia 2007 TOT 535
Small 543 74.4 92 e 42 12 49 10 68 11
Large 292 71.7 93 e 62 16 60 27 68 12
CHD: Coronary artery disease; CRF: Chronic renal failure; COPD: Chronic Obstructive Pulmonary Disease; ASA: American Society of
Anaesthesiologists score; HTN: Hypertension.

unpublished data.
x large AAA group was based on unpublished data.
166 P. De Rango et al.high (OR 0.48; 95% CI 0.25 to 0.95; test for heterogene-
ity; p¼ 0.08; Fig. 3).
Five studies reported on aneurysm rupture. Similar
differences were shown in longer (OR 0.58; 95% CI
0.39 to 0.87; test for heterogeneity p¼ 0.35) and shorter
follow-up subgroups (OR 0.63; 95% CI 0.44 to 0.88;
test for heterogeneity p¼ 1) in favour of the small
AAA group (Fig. 4).
Discussion
Currently there is no available evidence from RCT on
early and long-term efficacy of EVAR based on aneu-
rysm diameter. Therefore, the data for this systematic
review originated from non-randomized controlled
studies, of only fair quality. According to the analysis
of over 6,000 pooled cases, endovascular treatment forFig. 1. The odds of perioperative death for small versus large
inverse variance method. u/d: unpublished data.
Eur J Vasc Endovasc Surg Vol 35, February 2008small aneurysms in comparison to large aneurysms
was associated with a lower peri-operative mortality
rate. AAA-related mortality and AAA rupture at
a mean follow-up of 3.2 years and a maximum of 10
years also were lower in the small AAA group. Al-
though all-cause mortality also was lower in the small
AAA group, the results were not adjusted for age and
the small AAA patients were younger than the large
AAA patients.
The surgical decision to treat any aneurysm is
based on AAA diameter, expansion rate, patient’s
risk factors, centre experience with EVAR and ex-
pected long-term clinical benefit of treatment. There
are two major issues in this respect: the size of aneu-
rysm, which determines the risk of rupture, and the
case mix of patients in terms of age and co-
morbidities.AAA: weighted pooled results by random-effect model of
Fig. 2. The odds of all causes death for small versus large AAA: weighted pooled results with random-effect model of
inverse variance method. The odds of all causes death for small versus large AAA are stratified by follow-up length. u/d un-
published data.
167Outcome after Endografting in Small and Large Abdominal Aortic AneurysmsA number of questions arise from the results of this
review on the challenging issue of small AAA treat-
ment. 1) Why did large AAA diameter have higher
peri-operative mortality rates? 2) What are the
durability and the clinical benefit of this treatment
effect?
The answer to the first question is complex. Differ-
ences might be due to different patterns of risk factors
between the two groups of patients with large and
small aneurysms. Small AAA may represent an ear-
lier stage of the disease in healthier patients who
have better outcome from treatment. On the other
hand, a large body of data suggests that large AAA
is more likely to be associated with hostile anatomy
and this is an issue in explaining difference in out-
comes.24e28 Morphological studies suggest that small
AAA have less complex anatomy, with longer aortic
necks, less neck angulation and less tortuosity, while
AAA maximum diameter is inversely related to the
length of the aortic neck.25 Aneurysm diameter may
be the most useful surrogate determinant of feasibility
for EVAR.25,26 Welborn et al. previously reported that
64% of patients with small AAA are candidates for
EVAR, whereas only 39% with large AAA are suitable
for EVAR when the manufacturers’ instructions for
use are strictly followed.24 Furthermore, the expan-
sion of small AAAs is associated with anatomicchanges in aortic aneurysm morphology with a signif-
icant change in suitability for EVAR. A relationship
between the growth of aneurysms and shorter and
wider proximal aortic necks has been demonstrated.
These changes may affect aneurysm suitability for
EVAR during the surveillance period.26e30
What are the durability of this treatment effect and
the long-term clinical benefit for small AAA? Indeed,
if the rupture risk in unrepaired small AAA is not
large enough, treatment would not be indicated. Liter-
ature data based on 5- year survival curves showed
that freedom from AAA-related death ranged from
97.2% to 99% and all cause survival rates from 69%
to 84.2%.7,8,20 Data from this review (after excluding
studies with short follow-up) showed a difference in
rupture rate (OR 0.58; 95% CI 0.39 to 0.87) persisting
up to 10 years in favour of aneurysms treated at
a smaller size. However, risk of rupture needs to be
assessed with stronger evidence comparing EVAR
versus surveillance.
Based on these two question-points, since optimal
EVAR suitability or no co-morbidities, are more fre-
quently found in patients with small AAAs, the strat-
egy to treat small AAA might be considered an
elective early treatment that can offer better outcomes.
At the same time, there is the objection that the risk of
aneurysm-related death in small aneurysms is per seEur J Vasc Endovasc Surg Vol 35, February 2008
Fig. 3. The odds of aneurysm-related death for small versus large AAA: weighted pooled results by random-effect model
of inverse variance method. The odds of aneurysm related death for small versus large AAA stratified by follow-up length.
u/d unpublished data.
168 P. De Rango et al.low, due to the low rupture rates found in patients un-
der surveillance and early EVAR may produce unnec-
essary operations.1,2,31,32 The level 1 evidence on
EVAR from the UK EVAR trials has demonstrated
the peri-operative superiority of EVAR in fit patients
with large AAA with respect to open surgery (OR
0.24; P¼ 0.030).33 Even if this evidence is translated
to small AAA there is still need for further direct level
1 evidence.
EVAR also is affected by need for re-intervention.
According to this review differences in re-intervention
and conversion rates were not significantly less in the
small AAA group. This may underscore the need for
further technological improvement in terms of dura-
bility of the available endografts. On the other hand,
suitability is the key to success for EVAR.
At present, the treatment of small aneurysms is
mainly conservative in most centres while interven-
tion is reserved for those expanding beyond a diame-
ter limit of 5.5 cm. Evidence supporting this policy is
provided by two large randomized trials showing that
early elective open surgery conferred no long-term
survival benefits.1,2 From these studies it also became
evident that approximately 70% of these small AAA
will require ‘‘delayed’’ treatment within 5 years be-
cause of significant enlargement or, less likely, symp-
toms. Since the 12 year results from the UKSAT
concluded for no long-term survival benefit of earlyEur J Vasc Endovasc Surg Vol 35, February 2008elective open repair of small AAA,2 it could be as-
sumed that patients with small AAA may be safely
left untreated for the first 5e6 years in centers where
there is a surveillance program. A controversy may
derive from the fact that early EVAR in patients
with good suitability could be a primary choice in
centres with experienced endovascular teams low
peri-operative risks and reliable follow-up schedule.
Based on the present review, today the decision to
treat a patient with small AAA by EVAR is not justi-
fied outside a randomized controlled trial. At the
same time, it is premature to use comparisons with ei-
ther open surgery or unfit patients to mount an argu-
ment against EVAR for small AAA.31,32Study limitations
The pooled data from these non-randomized series of
only fair quality cannot provide level 1 evidence.
Therefore, our results should be used with caution.
Selection or publication bias between the populations
at comparison may have impacted on our findings.
Differences in co-morbidities and case mix could
influence the outcome of patients with large versus
small AAA, particularly in terms of survival where
no adjustments were made for age and other
differences.
Fig. 4. The odds of rupture for small versus large AAA: weighted pooled results by random effect model of inverse variance
method. The odds of rupture for small versus large AAA are stratified by follow-up length. u/d unpublished data p/u:
published and unpublished data.
169Outcome after Endografting in Small and Large Abdominal Aortic AneurysmsThis is a review on results of EVAR on small and
large aneurysm and not an observational study on
small aneurysms. Information on a surveillance group
is lacking. Therefore, the key question as to whether
‘‘watchful waiting’’ and delayed treatment is better
or worse than early EVAR in a suitable population
could not be addressed.Fig. 5. The odds of conversion during follow-up for small
effect model of inverse variance method). All studies with
data; p/u: published and unpublished data.Furthermore, variability in length and adherence to
follow-up, sample size, and patient inclusion criteria,
as patients at different surgical risk, among the stud-
ies should also be taken into account.
Although this review used studies from the period
2000 to early 2007, some of the published experiences
may have used outdated device technology.versus large AAA (weighted pooled results by random-
mean follow-up longer than 24 months. u/d unpublished
Eur J Vasc Endovasc Surg Vol 35, February 2008
Fig. 6. The odds of reintervention during follow-up for small versus large AAA (weighted pooled results by random-effect
model of inverse variance method). All studies with mean follow-up longer than 24 months. u/d unpublished data; p/d:
published and unpublished data.
170 P. De Rango et al.Conclusions
The results of the present meta-analysis, with the
above specified limitations, suggest that EVAR in
small versus large AAA was associated with a better
outcome for peri-operative and aneurysm-related
mortality. Screening and surveillance programs play
a key role in small aneurysm management. The de-
bate about surveillance or EVAR for small aneurysms
has not been answered and better evidence is
required. Whether EVAR applied to small AAA pro-
duces more benefits than hazards due to over treat-
ment needs to be assessed by randomized trials
comparing early endografting versus surveillance.34,35
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Early and long-term outcome of a consecutive series
of 835 EVAR performed at the authors own single cen-
tre from April 1997 to January 2007 were reviewed.
Only patients treated electively with commercially
available devices were included: 336 Zenith (Cook,Eur J Vasc Endovasc Surg Vol 35, February 2008Bloomington, IN, USA), 238 AneuRx (Medtronic AVE,
Santa Rosa, CA, USA), 117 Talent (Medtronic AVE,
Santa Rosa, CA, USA), 92 Excluder (WL Gore &
Associates, Sunnyvale, CA, USA), 35 Fortron (Cordis,
Johnson & Johnson, Warren, NJ, USA), 13 Anaconda
(Sulzer Vascutek, Edinburgh, UK), 3 Endologix (Bard,
Irvine, CA, USA), 1 Endomed (Endomed, Phoenix,
AZ, USA) were implanted.
Patients were followed-up by periodic clinical ex-
amination, duplex ultrasound, X-ray and computed
tomographic (CT) scan. Mean follow-up was 39.2
months (range 1e114 months; median 32 months).
Aneurysm diameter was defined as the minimum
transverse aneurysm diameter at the maximum
expansion level as measured on CT scan. Mean
preoperative aneurysm size was 53.4 mm, range 40e
100 mm. (median 51). We used the customary
threshold diameter to compare patients with small an-
eurysms (< 5.5 cm) to patients with large aneurysms
(> 5.5 cm).
Differences between the two groups were assessed
for significance using the c square for binary factors
and the t-test for continuous factors. Long-term out-
comes were expressed as life table estimates with
standard errors and compared using the log-rank
test. Statistical significance was defined as P< 0.05.
Statistical analyses were performed using SPSS soft-
ware (SPSS Inc., Chicago, IL, USA).Results
Of the overall 835 patients, 543 (65%) underwent EVAR
for aneurysms smaller than 5.5 cm in diameter and 292
(35%) for aneurysms 5.5 cm or larger in diameter.
171Outcome after Endografting in Small and Large Abdominal Aortic AneurysmsWith respect to risk factors, patients with large an-
eurysms were older (74.4 vs. 71.7 years, p¼ .0001) and
more prone to coronary heart disease (50% vs. 42%,
p¼ 0.01) and chronic obstructive pulmonary disease
(60% vs. 49%, p¼ 0.02) than patients with small aneu-
rysms. With respect to the anatomical features, pa-
tients with large AAA were more prone to have
neck< 10 mm (9% vs. 4%, p¼ 0.001), angulated neck
(23% vs. 13%, p¼ 0.001) and associated iliac aneurysm
(32% vs. 21%, p¼ 0.001) than patients with small
AAA. There were 9 perioperative deaths, 6 in the
large group and 3 in the small group. Furthermore,
6 ruptures (3 in each group), 47 conversions to open
repair (30 in the small group and 17 in the large
group) and 95 reinterventions (62 in the small group
and 33 in the large group) occurred. At 96 months
of follow-up life table analysis showed that patient
survival decreased (49% vs. 65%; p< .0001), risk of
aneurysm-related death (4.1% % vs. 1.3%; p¼ .05)
and risk of reintervention after EVAR (50% vs. 35%;
p¼ 0.018) increased in the group with large aneu-
rysms. Risk of rupture (5.7% vs. 1.1%) and risk of con-
version (13.9% vs. 22.6%) also increased in the group
of large AAA but these data did not reach statistical
significance.References
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